Search - tctmd.com

Displaying 101 - 120 of 535

Sort: Relevancy | Date

Presentation NY Valves 2024

A Reduction in Percent Oversizing of Newer Generation Balloon-Expandable Transcatheter Aortic Valves Does Not Affect Severity of Paravalvular Regurgitation

Presenter: Riya Murugesan

June 06, 2024

Presentation NY Valves 2024

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Presenter: Arianna Favela

June 06, 2024

Presentation NY Valves 2024

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Presenter: Torsten P. Vahl

June 05, 2024

Presentation NY Valves 2024

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Presenter: Raj Makkar

June 05, 2024

Presentation NY Valves 2024

Why is TAVR Needed for Chronic Severe AR: Contemporary Insights

Presenter: Vinod H. Thourani

June 05, 2024

Presentation NY Valves 2024

What's Needed to "Modernize" the Guidelines for Chronic Severe Aortic Regurgitation?

Presenter: Santiago Garcia

June 05, 2024

Presentation NY Valves 2024

Trilogy TAVR in the Real World: An EU Implanter’s Experience with the Trilogy System

Presenter: Matti Adam

June 05, 2024

Presentation NY Valves 2024

The Trilogy TAVR System and an Update on the ALIGN-AR Study

Presenter: Raj Makkar

June 05, 2024

Presentation NY Valves 2024

Is Underdiagnosis of AR a Real Problem? Imaging Methods for the Evaluation of Aortic Regurgitation

Presenter: Vera Rigolin

June 05, 2024

Presentation NY Valves 2024

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

Advertisement

A Reduction in Percent Oversizing of Newer Generation Balloon-Expandable Transcatheter Aortic Valves Does Not Affect Severity of Paravalvular Regurgitation

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Why is TAVR Needed for Chronic Severe AR: Contemporary Insights

What's Needed to "Modernize" the Guidelines for Chronic Severe Aortic Regurgitation?

Trilogy TAVR in the Real World: An EU Implanter’s Experience with the Trilogy System

The Trilogy TAVR System and an Update on the ALIGN-AR Study

Is Underdiagnosis of AR a Real Problem? Imaging Methods for the Evaluation of Aortic Regurgitation

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

April 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Top Structural Heart News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content